Stocktoria
ArriVent BioPharma, Inc. AVBP
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2024-01-26
ArriVent BioPharma, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| Point72 Asset Management, L.P. | 748,195 | $17.3M | 1.76% |
| BlackRock Finance, Inc. | 663,265 | $12.3M | 1.56% |
| MILLENNIUM MANAGEMENT LLC | 425,923 | $9.8M | 1% |
| D. E. Shaw & Co., Inc. | 368,795 | $8.5M | 0.87% |
| CITADEL ADVISORS LLC | 353,257 | $8.1M | 0.83% |
| TWO SIGMA INVESTMENTS, LP | 48,682 | $1.1M | 0.11% |
| AQR CAPITAL MANAGEMENT LLC | 15,923 | $367,344 | 0.04% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.